ACLX
Price
$67.25
Change
-$2.13 (-3.07%)
Updated
Feb 5, 02:19 PM (EDT)
Capitalization
4.01B
21 days until earnings call
Intraday BUY SELL Signals
ARCT
Price
$7.21
Change
-$0.12 (-1.64%)
Updated
Feb 5, 02:22 PM (EDT)
Capitalization
208.28M
25 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACLX vs ARCT

Header iconACLX vs ARCT Comparison
Open Charts ACLX vs ARCTBanner chart's image
Arcellx
Price$67.25
Change-$2.13 (-3.07%)
Volume$400
Capitalization4.01B
Arcturus Therapeutics Holdings
Price$7.21
Change-$0.12 (-1.64%)
Volume$738
Capitalization208.28M
ACLX vs ARCT Comparison Chart in %
ACLX
Daily Signal:
Gain/Loss:
ARCT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACLX vs. ARCT commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a StrongBuy and ARCT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (ACLX: $69.38 vs. ARCT: $7.33)
Brand notoriety: ACLX and ARCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 65% vs. ARCT: 82%
Market capitalization -- ACLX: $4.01B vs. ARCT: $208.28M
ACLX [@Biotechnology] is valued at $4.01B. ARCT’s [@Biotechnology] market capitalization is $208.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileARCT’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • ARCT’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACLX and ARCT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 6 TA indicator(s) are bullish while ARCT’s TA Score has 4 bullish TA indicator(s).

  • ACLX’s TA Score: 6 bullish, 4 bearish.
  • ARCT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than ARCT.

Price Growth

ACLX (@Biotechnology) experienced а +1.82% price change this week, while ARCT (@Biotechnology) price change was -0.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.81%. For the same industry, the average monthly price growth was -1.54%, and the average quarterly price growth was +30.06%.

Reported Earning Dates

ACLX is expected to report earnings on Feb 26, 2026.

ARCT is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (-5.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($4.01B) has a higher market cap than ARCT($208M). ARCT YTD gains are higher at: 19.576 vs. ACLX (6.411). ARCT has higher annual earnings (EBITDA): -60.46M vs. ACLX (-209.52M). ACLX has more cash in the bank: 461M vs. ARCT (180M). ARCT has less debt than ACLX: ARCT (26M) vs ACLX (51.8M). ARCT has higher revenues than ACLX: ARCT (85.1M) vs ACLX (35.9M).
ACLXARCTACLX / ARCT
Capitalization4.01B208M1,929%
EBITDA-209.52M-60.46M347%
Gain YTD6.41119.57633%
P/E RatioN/AN/A-
Revenue35.9M85.1M42%
Total Cash461M180M256%
Total Debt51.8M26M199%
FUNDAMENTALS RATINGS
ARCT: Fundamental Ratings
ARCT
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXARCT
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 15 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signal:
Gain/Loss:
ARCT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRLVX20.530.25
+1.23%
Harbor Large Cap Value Admin
GEIZX18.18N/A
N/A
GuideStone Funds Growth Equity Index Inv
DLCFX16.34-0.01
-0.06%
Destinations Large Cap Equity I
EIERX21.78-0.12
-0.55%
Eaton Vance Stock I
VRGWX898.21-10.72
-1.18%
Vanguard Russell 1000 Growth Index I

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with OCUL. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-0.12%
OCUL - ACLX
57%
Loosely correlated
+0.47%
CRSP - ACLX
55%
Loosely correlated
-3.52%
AGIO - ACLX
55%
Loosely correlated
-0.82%
LENZ - ACLX
55%
Loosely correlated
-5.86%
ARCT - ACLX
54%
Loosely correlated
+0.14%
More

ARCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARCT has been closely correlated with VTGN. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARCT jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARCT
1D Price
Change %
ARCT100%
+0.14%
VTGN - ARCT
79%
Closely correlated
-3.20%
RZLT - ARCT
79%
Closely correlated
-7.62%
MREO - ARCT
78%
Closely correlated
-2.73%
QNCX - ARCT
75%
Closely correlated
+9.28%
LEGN - ARCT
73%
Closely correlated
-0.06%
More